Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions
NCT00553787
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2487
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Type 2 Diabetes
Interventions
DRUG:
VI-0521
DRUG:
VI-0521
DRUG:
VI-0521
Sponsor
VIVUS LLC
Collaborators
[object Object]